SUCCESSFUL USE OF SAMARIUM 153 FOR EMERGENCY TREATMENT OF DISSEMINATED INTRAVASCULAR COAGULATION DUE TO METASTATIC HORMONE REFRACTORY PROSTATE CANCER

Chronic disseminated intravascular coagulation is present in 13% to 30% of prostate cancer cases. In contrast, overt disseminated intravascular coagulation is rare (0.4% to 1.65%) but pejorative, arising in metastatic cases. We report the successful use of samarium 153 in a patient with metastatic hormone refractory disease.